English
Polski
Español
українська
At-home pharmacologic prophylaxis of thrombosis in immobilized patients
Pharmacologic prophylaxis of thrombosis in immobilized patients staying at home raises many doubts. Are there situations when it should be used?
2023-04-05
Pharmacologic prophylaxis of thrombosis in immobilized patients staying at home raises many doubts. Are there situations when it should be used?
Are there any guidelines discussing the length of treatment in patients with thrombosis of rare or unusual localizations, such as the subclavian or visceral (portal) vein? When to stop treatment?
How to interpret persistently elevated D-dimer levels in patients with a history of COVID-19? How to proceed in such cases?
Is an unexplained increase in the D-dimer level an indication to test for thrombophilia? Is it an indication to introduce antithrombotic prophylaxis?
Dr James Douketis from McMaster University shares his views on the 3 most important recent advances in the management of venous thrombosis.
Dr Adam Torbicki, professor of medicine at Center of Postgraduate Medical Education in Warsaw, Poland, presents the 3 most recent advances in treating pulmonary embolism.
Should we treat patients with suspected subsegmental pulmonary embolism seen on computed tomography (CT)?
Preliminary results of a survey among physicians show that many still consider the D-dimer test as the first choice to confirm an episode of venous thromboembolism (VTE). Could you comment on the value of the pretest probability evaluation before choosing an appropriate test?
What is the use of low-dose direct oral anticoagulants (DOACs) in venous thromboembolism (VTE)?
